{
    "document_number": "2025-02406",
    "pdf_url": "https://www.govinfo.gov/content/pkg/FR-2025-02-07/pdf/2025-02406.pdf",
    "publication_date": "2025-02-07",
    "title": "Imposing Duties To Address the Flow of Illicit Drugs Across Our Northern Border",
    "summary": "Executive Order 14193, issued by President Donald J. Trump on February 1, 2025, addresses the urgent issue of illicit drug trafficking across the northern U.S. border, particularly focusing on the influx of opioids like fentanyl from Canada. The order cites a national emergency due to the severe public health crisis caused by these drugs, which have strained healthcare systems and endangered lives in the United States. \n\nKey findings include:\n- The involvement of drug trafficking organizations (DTOs) and Mexican cartels in smuggling operations, with Canada failing to adequately cooperate in combating this issue.\n- A significant amount of fentanyl entering the U.S. from Canada poses a lethal threat, with the potential to kill millions of Americans.\n- The order imposes a 25% ad valorem tariff on Canadian products, effective February 4, 2025, as a measure to compel Canada to take more effective action against drug trafficking.\n\nThe implications of this order include heightened tensions in U.S.-Canada relations and potential retaliatory measures from Canada. The order emphasizes the need for decisive action to protect U.S. citizens and restore border security, while also mandating ongoing assessments of Canada's cooperation in addressing these challenges.",
    "doc_type": "executive_order"
}